ProCE Banner Activity

Focus on GU Cancers: Current Clinical Experience With PD-1/PD-L1 Immune Checkpoint Inhibitors

Slideset Download
Download this slideset from Scot Niglio, MD to see an overview of how IO biomarkers are currently used for patients with GU cancers, with key data on immunotherapy approaches for bladder cancer, RCC, and prostate cancer.

Released: July 09, 2020

Expiration: July 08, 2021

No longer available for credit.

Share

Faculty

Scot Niglio

Scot Niglio, MD

Medical Oncologist
Bethesda, Maryland

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Scot Niglio, MD

Medical Oncologist
Bethesda, Maryland